Synergistic role of HSP90α and HSP90β to promote myofibroblast persistence in lung fibrosis
Pierre‐Simon Bellaye(Inserm), Martin Kolb(McMaster University)
Cited by 55
Related Papers
Nintedanib in Progressive Fibrosing Interstitial Lung Diseases
|New England Journal of Medicine|2019|2.3k
Control of Confounding and Reporting of Results in Causal Inference Studies. Guidance for Authors from Editors of Respiratory, Sleep, and Critical Care Journals
|Annals of the American Thoracic Society|2018|723
Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial
|The Lancet Respiratory Medicine|2020|558
What's in a name? That which we call IPF, by any other name would act the same
|European Respiratory Journal|2018|352
VEGF ameliorates pulmonary hypertension through inhibition of endothelial apoptosis in experimental lung fibrosis in rats
|Journal of Clinical Investigation|2009|221